Cite
HARVARD Citation
Ligorio, F. et al. (2022). Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab. Journal of the National Cancer Institute. pp. 1720-1727. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ligorio, F. et al. (2022). Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab. Journal of the National Cancer Institute. pp. 1720-1727. [Online].